BERLIN, Germany, September 6, 2019 – AMP German Cannabis Group Inc. (“AMP” or the “Company”) (CSE: XCX), (FSE: C4T, ISIN: CA00176G1028) announces that it has granted incentive stock options to purchase up to 2,120,000 common shares of the Company to certain directors, officers, employees and consultants in accordance with its stock option plan, including options to purchase up to 1,175,000 shares to certain directors and officers. Each option vests immediately has an exercise price of $0.50 per share and is exercisable for a period of one year from issuance.
About AMP German Cannabis Group Inc.
AMP German Cannabis Group is the parent company of several European investment subsidiaries focusing on the import of pharmaceutical-grade (EU-GMP) cannabis into Germany, predominantly from Canada. AMP provides EU-GMP gap analysis and audits, logistical, transportation, importation permits and other related services for the importation of medical cannabis into Germany through its AMP EU-GMP German Certification Protocol Program.
For more information, please visit: www.amp-eu.com.
Mr. Alex Blodgett, CEO and Director
This news release does not constitute an offer to sell or a solicitation of an offer to buy any of the shares in the United States. The shares have not been and will not be registered under the United States Securities Act of 1933, as amended (the “U.S. Securities Act”), or any state securities laws and may not be offered or sold within the United States or to U.S. Persons unless registered under the U.S. Securities Act and applicable state securities laws or an exemption from such registration is available.
This news release contains forward-looking statements that are based on the Company’s expectations, estimates and projections regarding its business and the economic environment in which it operates, including with respect to the completion of the offering, the timing thereof and the expected use of proceeds from the offering. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and involve risks and uncertainties that are difficult to control or predict. Therefore, actual outcomes and results may differ materially from those expressed in these forward-looking statements and readers should not place undue reliance on such statements. These forward-looking statements speak only as of the date on which they are made, and the Company undertakes no obligation to update them publicly to reflect new information or the occurrence of future events or circumstances unless otherwise required to do so by law.